IDEXX Labs (IDXX) Tops Q3 EPS by 27c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/22/2026
- Nasdaq leads Wall Street lower on AI spending jitters; oil prices rebound
- Meta’s new Class C stock to keep Zuckerberg in California, fund AI spending spree
- Brent hits five-month high on escalating Middle East conflict
- Meta beats Q3 estimates, approves new nonvoting share class as AI spending surges
- Tesla stock up as automotive gross margin improves, free cash flow turns positive
IDEXX Laboratories Announces Third Quarter Results
October 29, 2020 6:30 AM EDTWESTBROOK, Maine, Oct. 29, 2020 /PRNewswire/ --Â
Achieves revenue growth of 19% on a reported basis and 18% on an organic basis driven by Companion Animal Group Diagnostics recurring revenue growth of 23% reported and 21% organic High revenue growth supported by sustained strong global recovery in the pet healthcare market Delivers EPS of $1.69, representing 36% growth on a reported basis and 47% on a comparable constant currency basis, reflecting benefits from high CAG Diagnostics recurring revenue gains and proactive cost controlsIDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in... More



